anmelden
OMX Nordic 40
2.612,41
PKT
-23,79
PKT
-0,90
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.01.24 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 26.01.24 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 26.01.24 | Volvo (B) Sell | UBS AG | |
| 25.01.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 25.01.24 | Nokia Underweight | Barclays Capital | |
| 25.01.24 | Nokia Neutral | UBS AG | |
| 25.01.24 | Nokia Hold | Jefferies & Company Inc. | |
| 25.01.24 | Volvo (B) Sell | UBS AG | |
| 25.01.24 | Nokia Neutral | JP Morgan Chase & Co. | |
| 24.01.24 | Nokia Neutral | JP Morgan Chase & Co. | |
| 23.01.24 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | UBS AG | |
| 23.01.24 | Ericsson (Telefon L.M.Ericsson) (B) Neutral | JP Morgan Chase & Co. | |
| 23.01.24 | Ericsson (Telefon L.M.Ericsson) (B) Buy | Jefferies & Company Inc. | |
| 22.01.24 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 19.01.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 19.01.24 | Nokia Underweight | Barclays Capital | |
| 18.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 17.01.24 | Hennes Mauritz (H M, H&M) Underperform | Bernstein Research | |
| 16.01.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 16.01.24 | AstraZeneca Sell | UBS AG | |
| 15.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.01.24 | Volvo (B) Buy | Deutsche Bank AG | |
| 15.01.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 15.01.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 09.01.24 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 08.01.24 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 05.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 04.01.24 | ABB (Asea Brown Boveri) Market-Perform | Bernstein Research | |
| 03.01.24 | AstraZeneca Overweight | Barclays Capital | |
| 03.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 03.01.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 02.01.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 02.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.01.24 | Nokia Neutral | JP Morgan Chase & Co. | |
| 02.01.24 | Nokia Neutral | UBS AG | |
| 27.12.23 | AstraZeneca Buy | UBS AG | |
| 20.12.23 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 18.12.23 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 18.12.23 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
| 18.12.23 | Nokia Neutral | Goldman Sachs Group Inc. |